Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Treatment Options for Cutaneous Lupus: Medications, Topicals, and More

Written By

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by
Dr.
Sarah Daglis
ND
Updated On
October 8, 2024

Cutaneous lupus is an autoimmune condition where the immune system attacks healthy skin cells, causing red, scaly patches, rashes, and sores, often on sun-exposed areas like the face and arms. While not the same as systemic lupus, early treatment is essential to prevent long-term skin damage and scarring. 

Proper care can manage symptoms, reduce flare-ups, and prevent worsening conditions. This article covers treatment options, including medications, topical treatments, and lifestyle changes to help control symptoms and improve quality of life.

[signup]

Understanding Cutaneous Lupus

Cutaneous lupus is an autoimmune condition where the immune system attacks healthy skin cells, causing inflammation and skin problems. Unlike systemic lupus, which affects organs, cutaneous lupus targets the skin, often leading to rashes, sores, or lesions on sun-exposed areas like the face, neck, arms, and scalp.

Some people may also be sensitive to sunlight, triggering or worsening symptoms. The skin changes can range from mild to severe and, in some cases, may cause scarring or permanent discoloration.

Types of Cutaneous Lupus

Cutaneous lupus appears in three primary forms: acute, subacute, and chronic.

  • Acute Cutaneous Lupus (ACLE): Often linked to systemic lupus, ACLE features a "butterfly rash" across the cheeks and nose. It flares with disease activity or sun exposure but usually fades without scarring.
  • Subacute Cutaneous Lupus (SCLE): SCLE causes red, scaly patches or ring-shaped lesions on sun-exposed skin. These can last weeks or months, rarely scar, and are often triggered by sunlight.
  • Chronic Cutaneous Lupus (CCLE): Also called discoid lupus, CCLE causes thick, scaly patches that can scar. Lesions often appear on the face, ears, and scalp, sometimes leading to permanent hair loss.

Symptoms of Cutaneous Lupus

People with cutaneous lupus typically experience several skin-related symptoms. These can vary depending on the type of cutaneous lupus they have but may include:

  • Rashes: Red, raised, or scaly rashes are common, particularly in areas exposed to the sun. In acute cases, the butterfly rash is a key sign.
  • Lesions: These can range from small, red bumps to large, ring-shaped patches or thick, scaly plaques.
  • Skin Sensitivity: Many individuals with cutaneous lupus have photosensitivity, meaning their symptoms worsen with sun exposure.
  • Scarring: If left untreated, chronic cutaneous lupus, particularly discoid lupus, can lead to permanent scarring or skin discoloration.
  • Itching or Burning: The affected skin areas can be itchy or painful, especially during flare-ups.

Diagnosis of Cutaneous Lupus

Diagnosing cutaneous lupus often involves a combination of medical history, physical examination, and laboratory tests. Since the symptoms can resemble other skin conditions, doctors need to confirm the diagnosis through specific tests.

Skin Biopsy: A skin biopsy is one of the most reliable ways to diagnose cutaneous lupus. During this procedure, a small sample of the affected skin is removed and examined under a microscope for signs of lupus-related changes.

Blood Tests: Blood tests detect antibodies common in lupus patients, such as antinuclear antibodies (ANA). While these tests are more commonly associated with systemic lupus, they can help support a cutaneous lupus diagnosis if systemic involvement is suspected. 

Here are examples of these tests offered through Rupa Health:

Lab Work: Other tests may include checking for inflammation markers or ruling out infections and other skin conditions. Sunlight tests may also be conducted to confirm photosensitivity. Examples offered by Rupa Health are:

Medications for Cutaneous Lupus

Treating cutaneous lupus usually involves medications to manage symptoms, control flare-ups, and prevent skin damage. These drugs reduce inflammation and limit the immune system's attack on healthy skin cells. Depending on severity, doctors may prescribe oral medications or biologics.

Oral Medications

Hydroxychloroquine, initially used for malaria, is often the first treatment for cutaneous lupus. It helps reduce lesions, prevent flare-ups, and minimize scarring. Long-term use is generally safe, but regular eye exams are recommended due to a small risk of retinopathy.

For severe cases unresponsive to antimalarials, immunosuppressants like methotrexate or azathioprine may be used. They suppress the immune system to prevent skin damage but increase infection risk, requiring regular blood tests to monitor safety.

Corticosteroids

Corticosteroids, like prednisone, are used short-term to reduce inflammation during cutaneous lupus flares. While effective, they can cause side effects like weight gain and bone loss, so long-term use is avoided.

Once symptoms improve, doctors taper off corticosteroids and switch to safer medications like antimalarials or immunosuppressants for ongoing management.

Biologic Therapies

Biologic therapies are a newer treatment for autoimmune conditions like lupus, targeting specific parts of the immune system.

One of the most significant advancements in biologics for cutaneous lupus is belimumab. This drug targets the B-lymphocyte stimulator (BLyS) protein, which plays a vital role in the immune system's overactivity in lupus patients. It helps reduce the immune attack on healthy skin, decreasing inflammation and lesions.

Biologics like belimumab are often used for more severe cases or when other treatments don't work. They offer a more targeted approach with fewer side effects than traditional immunosuppressants.

Side Effects and Monitoring

Medications for cutaneous lupus can be effective but may cause side effects, so regular monitoring is essential. 

Antimalarials like hydroxychloroquine can cause eye issues, requiring regular eye exams. Immunosuppressants, such as methotrexate and azathioprine, increase infection risk and require blood tests to check liver function and blood cell counts.

Long-term corticosteroids can lead to bone thinning, weight gain, and high blood sugar, so they are typically used in the short term. Biologics like belimumab also increase infection risk but have fewer side effects than other immunosuppressants. 

Close monitoring is vital as it helps balance the benefits and risks of medications, ensuring effective treatment for cutaneous lupus while minimizing harm.

Topical Treatments for Cutaneous Lupus

Topical treatments are often the first choice for mild to moderate cutaneous lupus. They target affected areas to reduce inflammation, promote healing, and offer a less invasive option than systemic medications.

Topical Corticosteroids

Topical corticosteroids reduce inflammation in cutaneous lupus and help heal lesions. More potent steroids like clobetasol or betamethasone treat severe lesions but are used short-term to avoid skin thinning, especially on sensitive areas like the face.

Milder options like hydrocortisone are recommended for delicate areas, effectively reducing inflammation with less risk of side effects. Long-term use of corticosteroids is monitored closely to prevent skin thinning and other side effects. Non-steroid treatments are often used for ongoing management.

Topical Calcineurin Inhibitors

Topical calcineurin inhibitors like tacrolimus and pimecrolimus are used as alternatives to corticosteroids, especially on sensitive areas like the face, to avoid steroid side effects. These medications suppress immune activity in the skin without causing thinning.

  • Tacrolimus: Commonly used for facial lesions, it calms inflammation and treats sensitive areas prone to irritation.
  • Pimecrolimus: Similar to tacrolimus but milder, it is used for less severe lesions.

These treatments are often used long-term when steroids aren't tolerated. They may cause tingling and increase sun sensitivity, so exposure should be limited.

Moisturizers and Barrier Repair Creams

Keeping skin hydrated is crucial for managing cutaneous lupus, as dry skin can trigger flare-ups.

Moisturizers lock in moisture and create a protective barrier, helping reduce dryness and irritation. Barrier repair creams contain ceramides and fatty acids and restore the skin's natural barrier, protecting it from further damage.

Using fragrance-free, hypoallergenic products and moisturizers after bathing can help manage symptoms, especially when combined with other treatments.

Photoprotection and UV Avoidance

Sun exposure plays a significant role in triggering or worsening the symptoms of cutaneous lupus. Ultraviolet (UV) light from the sun and artificial sources like tanning beds can aggravate lupus-related skin lesions and increase the risk of flare-ups. 

For people with cutaneous lupus, practicing strict photoprotection is essential to manage their condition and prevent further skin damage.

Impact of Sun Exposure

UV light triggers cutaneous lupus, causing skin inflammation, new rashes, and worsening lesions. Sun exposure can also lead to permanent scarring or pigmentation changes by activating an abnormal immune response. 

Even brief exposure can cause flare-ups, especially in sun-exposed areas like the face, neck, and arms. UV light may also trigger fatigue and joint pain. Protecting the skin from UV rays is crucial to reducing flare-ups and preventing long-term damage.

Sunscreens

Using broad-spectrum sunscreen protects against UVA and UVB rays in cutaneous lupus.

  • SPF 30 or Higher: Choose sunscreens with SPF 30+ for strong protection, blocking about 97% of UVB rays.
  • Physical Sunscreens: Mineral-based sunscreens with zinc oxide or titanium dioxide are gentler on sensitive skin.
  • Daily Use: Apply sunscreen every day, even on cloudy days, and reapply every two hours, especially when outdoors.
  • Proper Application: Use enough to cover all exposed skin, including the face, neck, hands, and feet.

Sunscreen should be combined with other sun-blocking measures for optimal protection, as it cannot provide 100% protection on its own.

Clothing and Accessories

In addition to sunscreen, UV-blocking clothing and protective accessories are crucial for managing cutaneous lupus.

  • UV-Blocking Clothing: Clothes with a UPF rating of 50+ block 98% of UV rays. Long sleeves, pants, and high-necked tops offer extra protection for exposed areas.
  • Wide-Brimmed Hats: A 3-inch wide brim shields the face, neck, and ears from harmful UV rays. UV-blocking fabrics add even more protection.
  • Sunglasses: 100% UV protection sunglasses protect the eyes and surrounding skin.
  • Seeking Shade: Avoid direct sunlight, especially between 10 a.m. and 4 p.m., and use umbrellas or sun-blocking devices for extra protection.

Combining sunscreen with UV-blocking clothing helps prevent flare-ups and improves symptom control.

Lifestyle Modifications and Supportive Therapies

For individuals with cutaneous lupus, making specific lifestyle changes can be vital in managing symptoms and improving overall well-being. While medications are essential for controlling the disease, lifestyle modifications like dietary adjustments, stress management, and alternative therapies can help reduce the frequency and severity of flare-ups.

Dietary Adjustments

Your diet can impact inflammation, including in the skin. While no specific diet exists for cutaneous lupus, an anti-inflammatory diet may help reduce flare-ups.

  • Anti-Inflammatory Foods: Eating fruits, vegetables, whole grains, and healthy fats can reduce inflammation. Berries and leafy greens, which are high in antioxidants, and salmon and flaxseeds, which are omega-3-rich, are especially beneficial.
  • Supplements: Vitamin D and omega-3 supplements can support immune health and reduce inflammation. Turmeric (curcumin) may also help, though more research is needed.
  • Foods to Avoid: Processed foods high in sugar, unhealthy fats, and refined carbs can worsen inflammation.

A balanced, nutrient-rich diet may reduce inflammation and promote healthier skin for people with cutaneous lupus.

Stress Management Techniques

Stress is a known trigger for lupus flare-ups, as it can over-activate the immune system. Managing stress is crucial for controlling symptoms.

  • Mindfulness and Meditation: Practicing mindfulness and regular meditation can reduce stress and lower cortisol levels, helping prevent flare-ups.
  • Physical Activity: Low-impact exercises like yoga or indoor walking relieve stress, improve sleep, and boost mood without excessive sun exposure.
  • Breathing Exercises: Techniques like deep belly breathing or the 4-7-8 method can quickly reduce stress and calm the nervous system.

Incorporating these techniques into daily life can help reduce flare-ups and improve well-being.

Alternative Therapies

Some people with cutaneous lupus explore alternative therapies to ease their symptoms in addition to standard treatments. While these approaches don't replace medical care, they can add more comfort.

  • Acupuncture: This ancient practice uses fine needles to stimulate healing. Some find it helps ease pain, boost circulation, and bring calm. Though research specific to lupus is limited, reducing stress through acupuncture might help manage symptoms.
  • Massage Therapy: Gentle massage may melt away stress and ease muscle tension. Working with a therapist who understands lupus is essential, as some skin areas might be too sensitive for deep pressure.
  • Aromatherapy: Soothing scents like lavender or chamomile can calm the mind and may help with stress, which often triggers lupus flare-ups. Oils can be used in diffusers, baths, or massages, but always check with a healthcare provider before applying them to the skin.
  • Herbal Supplements: Herbs like ginger or green tea may offer anti-inflammatory benefits. However, it's essential to consult a doctor before using herbal remedies, as they might affect lupus medications.

These therapies can add gentle relief when combined with medical treatments but should always be explored under a doctor's guidance to ensure they blend safely into the overall care plan.

Emerging and Experimental Treatment

Research into cutaneous lupus is developing new, more targeted treatments to improve outcomes and reduce side effects. While many are still under investigation, they offer hope for better future care.

Investigational Drugs

Several investigational drugs are being tested to better control cutaneous lupus by targeting specific immune components to reduce inflammation and skin damage. Unlike traditional therapies, these newer drugs aim to be more targeted and have fewer side effects.

  • JAK Inhibitors: Drugs like tofacitinib and ruxolitinib block immune pathways, potentially reducing skin lesions and flare-ups. Early trials are promising, but more research is needed.
  • IFN Inhibitors: Anifrolumab blocks interferon activity, which is linked to lupus. It may reduce skin inflammation and has shown success in treating systemic lupus.
  • BTK Inhibitors: Fenebrutinib targets immune cells involved in inflammation, offering potential relief for lupus symptoms.

These drugs show promise, but more research is needed before they can be widely used.

Innovations in Treatment Modalities

In addition to new drug therapies, several innovations in treatment modalities may offer new ways to manage the skin symptoms of cutaneous lupus. These approaches focus on reducing inflammation and promoting healing through advanced technologies, offering alternative options for people who may not respond well to traditional medications.

Laser Therapy

Laser therapy is an emerging treatment for managing skin lesions in people with cutaneous lupus. Different types of lasers can be used to target inflamed areas, reduce redness, and promote skin healing. Some of the lasers being explored for lupus treatment include:

  • Pulsed Dye Laser (PDL): PDL explicitly targets blood vessels, helping to reduce the redness and inflammation seen in cutaneous lupus lesions. This type of laser is beneficial for treating vascular lesions or redness caused by the disease. Early studies suggest that PDL can improve the appearance of skin lesions and may even help prevent scarring.
  • Fractional Lasers: Fractional lasers promote skin regeneration and improve the texture and tone of the skin. These lasers create microscopic skin injuries, triggering the body's natural healing process without damaging the surrounding tissue. This approach may be beneficial for people with discoid lupus who experience scarring and skin damage.

Laser therapy is still being studied for its effectiveness in lupus. While early results are promising, more research is needed to establish how well it works in different types of cutaneous lupus.

Phototherapy

While sun exposure can worsen lupus, controlled exposure to narrowband ultraviolet B (UVB) light under medical supervision has shown potential in treating autoimmune skin conditions, including cutaneous lupus. 

Phototherapy works by modulating the immune response in the skin, reducing inflammation, and suppressing the abnormal immune activity that leads to skin lesions.

  • Narrowband UVB Therapy: This form of phototherapy delivers specific wavelengths of UVB light that target the immune cells in the skin. It can help reduce skin inflammation and prevent the development of new lesions. Phototherapy is typically administered in a clinical setting, and sessions are carefully monitored to avoid overexposure to UV light.
  • Low-Level Light Therapy (LLLT): LLLT, or cold laser therapy, uses low-intensity light to stimulate healing without damaging skin damage. It has been studied for various skin conditions, and there is growing interest in its potential for managing cutaneous lupus. LLLT may help reduce inflammation and promote tissue repair, offering another option for treating lupus-related skin lesions.

Phototherapy and laser treatments are considered experimental for cutaneous lupus, and their use is generally limited to clinical trials or specialized centers. However, as research continues, these approaches may become more widely available for patients who need additional options beyond medication.

Managing Flare-Ups and Long-Term Care

Managing flare-ups is critical to maintaining skin health for people with cutaneous lupus. If untreated, flare-ups can cause discomfort and permanent damage. By recognizing early signs and using long-term management strategies, patients can better control the condition and prevent complications.

Signs of a Flare-Up

Recognizing early signs of a cutaneous lupus flare-up helps prevent worsening symptoms. Triggers include sun exposure, stress, or infections. Warning signs may include:

  • New or worsening skin lesions, such as red, scaly rashes on sun-exposed areas.
  • Increased sensitivity to sunlight causes rashes to appear or worsen.
  • Skin discoloration in areas where lesions are developing.
  • Itching or burning sensations in affected areas before visible changes appear.

By spotting these signs early, individuals can adjust treatments or increase sun protection to manage flare-ups and reduce skin damage.

Long-Term Management Strategies

Managing cutaneous lupus requires long-term care, regular monitoring, and lifestyle adjustments to prevent flare-ups. Regular dermatologist visits and sticking to treatments, including medications and sunscreen, are essential. 

Sun protection with SPF 30+ and UV-blocking clothing is crucial. Tracking symptoms and triggers like stress or sun exposure helps refine management and protect the skin.

Patient Education

Educating patients about cutaneous lupus is essential for long-term management. Understanding the condition helps patients follow treatments and make lifestyle changes. 

Healthcare providers should explain lupus, triggers, treatments, and sun protection, including sunscreen and protective clothing. Managing stress, eating well, and good sleep habits also help. Providers can offer resources like the Lupus Foundation or NIH for additional support.

[signup]

Key Takeaways

  • Treatment options for cutaneous lupus include oral medications like antimalarials, immunosuppressants, corticosteroids, and newer biologic therapies such as belimumab for more severe cases.
  • Topical treatments, including corticosteroids and calcineurin inhibitors, help manage skin inflammation directly, while moisturizers and barrier repair creams are essential for maintaining healthy skin and reducing irritation.
  • Lifestyle changes like sun protection, anti-inflammatory diets, and stress management techniques can help reduce lupus flare-ups, improving long-term disease control and quality of life.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No lab tests!

Aleksandra Fijałkowska, Kądziela, M., & Agnieszka Żebrowska. (2024). The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review. Journal of Clinical Medicine, 13(8), 2419–2419. https://doi.org/10.3390/jcm13082419

Alexiades-Armenakas, M. R., Dover, J. S., & Arndt, K. A. (2012). Fractional laser skin resurfacing. Journal of Drugs in Dermatology: JDD, 11(11), 1274–1287. https://pubmed.ncbi.nlm.nih.gov/23135075/

ANA 11 Components (no ANA Screen) by Access Med Labs. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/access-medical-labs-ana-11-components-no-ana-screen

ANA by Empire City Laboratories Inc. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/empire-city-labs-ana

ANA Screen by Access Medical Laboratories. (n.d.). Rupa Health. https://www.rupahealth.com/lab-tests/access-medical-labs-ana-screen

Avci, P., Gupta, A., Sadasivam, M., Vecchio, D., Pam, Z., Pam, N., & Hamblin, M. R. (2013). Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Seminars in Cutaneous Medicine and Surgery, 32(1), 41–52. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126803/

Bernstein EF. (2024). The pulsed-dye laser for treatment of cutaneous conditions. Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia, 144(5). https://pubmed.ncbi.nlm.nih.gov/19834434/

Bertagna, B. (2023, December 28). Health Benefits of Green Tea and How to Include It in Your Diet. Rupa Health. https://www.rupahealth.com/post/health-benefits-of-green-tea-and-how-to-include-it-in-your-diet

Blake, K. (2023, May 22). Anti Inflammatory Diet 101: What to Eat and Avoid Plus Specialty Labs To Monitor Results. Rupa Health. https://www.rupahealth.com/post/anti-inflammatory-diet

Blake, S. C., & Daniel, B. S. (2019). Cutaneous lupus erythematosus: A review of the literature. International Journal of Women's Dermatology, 5(5), 320–329. https://doi.org/10.1016/j.ijwd.2019.07.004

Blyth, C., & Lane, C. M. (1998). Hydroxychloroquine retinopathy: is screening necessary? BMJ, 316(7133), 716–717. https://doi.org/10.1136/bmj.316.7133.716

Buchman, A. L. (2001). Side Effects of Corticosteroid Therapy. Journal of Clinical Gastroenterology, 33(4), 289–294. https://doi.org/10.1097/00004836-200110000-00006

Bui, A., & Sanghavi, D. (2022). Anifrolumab. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK555979/

C-Reactive Protein, Inflammation (CRP) by Access Medical Laboratories. (n.d.). Rupa Health. https://www.rupahealth.com/lab-tests/access-medical-labs-c-reactive-protein-inflammation-crp

C-Reactive Protein, Inflammation (CRP) by Access Labcorp Draw. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/labcorp-c-reactive-protein-inflammation-crp

Chang, A. Y., & Werth, V. P. (2011). Treatment of Cutaneous Lupus. Current Rheumatology Reports, 13(4), 300–307. https://doi.org/10.1007/s11926-011-0180-z

Cleveland Clinic. (2022, September 5). How To Do the 4-7-8 Breathing Exercise. Cleveland Clinic. https://health.clevelandclinic.org/4-7-8-breathing

Cloyd, J. (2023a, July 14). A Functional Medicine Osteopenia Protocol: Testing, Nutrition, and Specialized Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-osteopenia-protocol-testing-nutrition-and-specialized-supplements

Cloyd, J. (2023b, October 16). How You Can Use Ginger Every Day To Relieve Pain, Improve Digestion, And Boost Heart Health. Rupa Health. https://www.rupahealth.com/post/top-5-therapeutic-uses-of-ginger

Cloyd, K. (2023c, October 3). Functional Medicine Protocol for Autoimmune Diseases: Balancing the Immune System. Rupa Health. https://www.rupahealth.com/post/functional-medicine-protocol-for-autoimmune-diseases-balancing-the-immune-system

Cloyd, J. (2023d, December 28). Which Patients Should You Run An ANA Test On? Rupa Health. https://www.rupahealth.com/post/which-patients-should-you-run-an-ana-test-on

Cloyd, J. (2023e, September 8). A Functional Medicine Approach to Addressing Hair Loss in Women. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-addressing-hair-loss-in-women

Cojocaru, M., Cojocaru, I. M., Silosi, I., & Vrabie, C. D. (2011). Manifestations of systemic lupus erythematosus. Maedica, 6(4), 330–336. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391953/

Cortisol. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/cortisol

DePorto, T. (2023, January 6). Omega 3's: The Superfood Nutrient You Need To Know About. Rupa Health. https://www.rupahealth.com/post/omega-3s-the-superfood-nutrient-you-need-to-know-about

Dillon, S. R., Harder, B., Lewis, K. B., Moore, M. D., Liu, H., Bukowski, T. R., Hamacher, N. B., Lantry, M. M., Maurer, M., Krejsa, C. M., Ellsworth, J. L., Pederson, S., Elkon, K. B., Wener, M. H., Dall’Era, M., & Gross, J. A. (2010). B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B cell maturation antigen-immunoglobulin. Arthritis Research & Therapy, 12(2), R48–R48. https://doi.org/10.1186/ar2959

Eastham, A. B., & Vleugels, R. A. (2014). Cutaneous Lupus Erythematosus. JAMA Dermatology, 150(3), 344. https://doi.org/10.1001/jamadermatol.2013.10393

Fujii, M. (2021). The Pathogenic and Therapeutic Implications of Ceramide Abnormalities in Atopic Dermatitis. Cells, 10(9), 2386. https://doi.org/10.3390/cells10092386

Haq, M., & Adnan, G. (2022). Ruxolitinib. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK570600/

Henry, E. (2022, January 4). How To Reverse Weight Gain And Slowed Metabolism. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-slow-metabolism-middle-age

High Sensitivity C-Reactive Protein (hsCRP) by ZRT Laboratory. (n.d.). Rupa Health. https://www.rupahealth.com/lab-tests/zrt-laboratory-high-sensitivity-c-reactive-protein-hscrp

High-Sensitivity C-Reactive Protein by Empire City Laboratories Inc. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/empire-city-labs-high-sensitivity-c-reactive-protein

Hodgens, A., & Sharman, T. (2023). Corticosteroids. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554612/

Hui-Yuen, J. S., Li, X. Q., & Askanase, A. D. (2015). Belimumab in systemic lupus erythematosus: a perspective review. Therapeutic Advances in Musculoskeletal Disease, 7(4), 115–121. https://doi.org/10.1177/1759720X15588514

Inflammation Panel by Ayumetrix. (n.d.). Rupa Health. https://www.rupahealth.com/lab-tests/ayumetrix-inflammation-panel

Isenberg, D., Furie, R., Jones, N. S., Guibord, P., Galanter, J., Lee, C., McGregor, A., Toth, B., Rae, J., Hwang, O., Desai, R., Lokku, A., Ramamoorthi, N., Hackney, J. A., Miranda, P., Souza, V. A., Jaller‐Raad, J. J., Maura Fernandes, A., Garcia Salinas, R., & Chinn, L. W. (2021). Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial. Arthritis & Rheumatology, 73(10), 1835–1846. https://doi.org/10.1002/art.41811

Jatwani, S., & Hearth Holmes, M. P. (2022). Subacute Cutaneous Lupus Erythematosus. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554554/

Johns Hopkins Lupus Center. (2017). Treating Lupus with Immunosuppressive Medications: Johns Hopkins Lupus Center. Johns Hopkins Lupus Center. https://www.hopkinslupus.org/lupus-treatment/lupus-medications/immunosuppressive-medications/

Keyes, E., Borucki, R., Feng, R., Grinnell, M., Vazquez, T., Diaz, D., & Werth, V. P. (2022). Preliminary definition of flare in cutaneous lupus erythematosus using the Cutaneous Lupus Erythematosus Disease Area and Severity Index. Journal of the American Academy of Dermatology, 87(2), 418–419. https://doi.org/10.1016/j.jaad.2021.08.036

Khakham, C. (2023a, March 7). Top Medical Evidence Supporting Curcumin's Health Benefits. Rupa Health. https://www.rupahealth.com/post/top-medical-evidence-supporting-curcumins-health-benefits

Khakham, C. (2023b, June 2). Top evidence-based herbal medicine and essential oil options for skin health and healing. Rupa Health. https://www.rupahealth.com/post/top-evidence-based-herbal-medicine-and-essential-oil-options-for-skin-health-and-healing

Khakham, C. (2023c, June 30). Integrative approaches to the treatment of lupus: A comprehensive review. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-the-treatment-of-lupus-a-comprehensive-review

Kuhn, A., Gensch, K., Haust, M., Meuth, A.-M., Boyer, F., Dupuy, P., Lehmann, P., Metze, D., & Ruzicka, T. (2011). Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: A randomized, vehicle-controlled, double-blind study. Journal of the American Academy of Dermatology, 64(1), 37–48. https://doi.org/10.1016/j.jaad.2009.12.053

Lehmann, P., & Homey, B. (2009). Clinic and pathophysiology of photosensitivity in lupus erythematosus. Autoimmunity Reviews, 8(6), 456–461. https://doi.org/10.1016/j.autrev.2008.12.012

Lu, J. T., & Ilyas, E. (2022). An Overview of Ultraviolet-Protective Clothing. Cureus, 14(7). https://doi.org/10.7759/cureus.27333

Luger, T., & Paul, C. (2007). Potential New Indications of Topical Calcineurin Inhibitors. Dermatology, 215(1), 45–54. https://doi.org/10.1159/000102119

Lupus Foundation of America. (2020). UV exposure: What you need to know. Lupus Foundation of America. https://www.lupus.org/resources/uv-exposure-what-you-need-to-know

Lupus Foundation of America. (2019). Help Us Solve The Cruel Mystery. Lupus Foundation of America. https://www.lupus.org/

Madnani, N., Deo, J., Dalal, K., Benjamin, B., Murthy, V. V., Hegde, R., & Shetty, T. (2024). Revitalizing the skin: Exploring the role of barrier repair moisturizers. https://doi.org/10.1111/jocd.16171

Maholy, N. (2023a, April 14). How to reduce stress through mind-body therapies. Rupa Health. https://www.rupahealth.com/post/how-to-reduce-stress-through-mind-body-therapies

Maholy, N. (2023b, May 17). A Functional Medicine Eye Health Protocol: Testing, Supplements, and Best Nutrition. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-eye-health-protocol

Maholy, N. (2023c, May 26). Integrative Nutrition Approaches to Managing Blood Sugar Levels. Rupa Health. https://www.rupahealth.com/post/integrative-nutrition-approaches-to-managing-blood-sugar-levels

Mahta Mortezavi, & Mysler, E. (2023). Clinical scenarios-based guide for tofacitinib in rheumatoid arthritis. 14. https://doi.org/10.1177/20406223231178273

Malani, S. (2023, February 22). Inflammatory Markers 101: How To Interpret. Rupa Health. https://www.rupahealth.com/post/inflammatory-markers-101-what-do-they-mean

Metz, M., Sussman, G., Gagnon, R., Staubach, P., Tanus, T., Yang, W. H., Lim, J. J., Clarke, H. J., Galanter, J., Chinn, L. W., Chu, T., Teterina, A., Burgess, T., Haddon, D. J., Lu, T. T., & Maurer, M. (2021). Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial. Nature Medicine, 27(11), 1961–1969. https://doi.org/10.1038/s41591-021-01537-w

Naji Rad, S., & Vashisht, P. (2020). Malar Rash. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK555981/

National Institutes of Health (NIH). (2023). National Institutes of Health (NIH). National Institutes of Health (NIH); US Department of Health and Human Services. https://www.nih.gov/

Oakley, A. M., Badri, T., & Harris, B. W. (2022). Photosensitivity. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK431072/

Okon, L. G., & Werth, V. P. (2013). Cutaneous lupus erythematosus: Diagnosis and treatment. Best Practice & Research Clinical Rheumatology, 27(3), 391–404. https://doi.org/10.1016/j.berh.2013.07.008

Presto, J. K., & Werth, V. P. (2016). Cutaneous Lupus Erythematosus: Current Treatment Options. Current Treatment Options in Rheumatology, 2(1), 36–48. https://doi.org/10.1007/s40674-016-0033-z

Purnamawati, S., Indrastuti, N., Danarti, R., & Saefudin, T. (2017). The Role of Moisturizers in Addressing Various Kinds of Dermatitis: A Review. Clinical Medicine & Research, 15(3-4), 75–87. https://doi.org/10.3121/cmr.2017.1363

Ramsey, M. L., & Rostami, S. (2020). Skin Biopsy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470457/

Rosman, Z., Shoenfeld, Y., & Zandman-Goddard, G. (2013). Biologic therapy for autoimmune diseases: an update. BMC Medicine, 11(1). https://doi.org/10.1186/1741-7015-11-88

Sato, E. I. (2001). Methotrexate therapy in systemic lupus erythematosus. Lupus, 10(3), 162–164. https://doi.org/10.1191/096120301666080831

Shi, H., Gudjonsson, J. E., & Kahlenberg, J. M. (2020). Treatment of cutaneous lupus erythematosus. Current Opinion in Rheumatology, 32(3), 208–214. https://doi.org/10.1097/bor.0000000000000704

Shipman, W. D., Vernice, N. A., Demetres, M., & Jorizzo, J. L. (2020). An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review. Journal of the American Academy of Dermatology, 82(3), 709–722. https://doi.org/10.1016/j.jaad.2019.07.027

Sweetnich, J. (2023a, May 4). Getting to Know Vitamin D: From Testing to Supplementing and Meeting your RDA's. Rupa Health. https://www.rupahealth.com/post/vitamin-d-101-testing-rdas-and-supplementing

Sweetnich, J. (2023b, June 30). Top 5 Antioxidants That Can Improve Your Health and How To Test Your Patient's Levels. Rupa Health. https://www.rupahealth.com/post/top-5-antioxidants-to-improve-your-health

Szczęch, J., Samotij, D., Werth, V. P., & Reich, A. (2017). Trigger factors of cutaneous lupus erythematosus: a review of current literature. Lupus, 26(8), 791–807. https://doi.org/10.1177/0961203317691369

Teeter, L. A. (2023, April 3). Mental health benefits of yoga and meditation. Rupa Health. https://www.rupahealth.com/post/mental-health-benefits-of-yoga-and-meditation

Trend, S., Leffler, J., Cooper, M. N., Byrne, S. N., Kermode, A. G., French, M. A., & Hart, P. H. (2020). Narrowband UVB phototherapy reduces TNF production by B‐cell subsets stimulated via TLR7 from individuals with early multiple sclerosis. Clinical & Translational Immunology, 9(10). https://doi.org/10.1002/cti2.1197

Vale, E. C. S. do, & Garcia, L. C. (2023). Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects. Anais Brasileiros de Dermatologia. https://doi.org/10.1016/j.abd.2022.09.005

Vilas-Boas, A., Morais, S. A., & Isenberg, D. A. (2015). Belimumab in systemic lupus erythematosus. RMD Open, 1(1), e000011–e000011. https://doi.org/10.1136/rmdopen-2014-000011

Weinberg, J. (2023, July 13). Integrative Approaches to Sun Protection: Thinking Beyond Sunscreen. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-sun-protection-thinking-beyond-sunscreen

Winkelmann, R. R., Kim, G. K., & Del Rosso, J. Q. (2013). Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria. The Journal of Clinical and Aesthetic Dermatology, 6(1), 27–38. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543290/

Yoshimura, H. (2023a, April 11). Using Acupuncture for Chronic Pain Management. Rupa Health. https://www.rupahealth.com/post/using-acupuncture-for-chronic-pain-management

Yoshimura, H. (2023b, May 8). A Functional Medicine Systemic Lupus Erythematosus (SLE) Protocol: Testing, Diagnosing, and Treatment. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-systemic-lupus-erythematosus-sle-protocol-testing-diagnosing-and-treatment

Yoshimura, H. (2024, April 8). Evidence-Based Review: The Role of Anti-Inflammatory Foods. Rupa Health. https://www.rupahealth.com/post/evidence-based-review-the-role-of-anti-inflammatory-foods

Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
National Library of Medicine
Government Authority
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
National Cancer Institute
Government Authority
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source